120 related articles for article (PubMed ID: 36018521)
21. Lymph node yield is an independent predictor of survival in rectal cancer regardless of receipt of neoadjuvant therapy.
Xu Z; Berho ME; Becerra AZ; Aquina CT; Hensley BJ; Arsalanizadeh R; Noyes K; Monson JRT; Fleming FJ
J Clin Pathol; 2017 Jul; 70(7):584-592. PubMed ID: 27932667
[TBL] [Abstract][Full Text] [Related]
22. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with operable breast cancer and positive axillary nodes at initial diagnosis.
Rebollo-Aguirre AC; Gallego-Peinado M; Sánchez-Sánchez R; Pastor-Pons E; García-García J; Chamorro-Santos CE; Menjón-Beltrán S
Rev Esp Med Nucl Imagen Mol; 2013; 32(4):240-5. PubMed ID: 23684711
[TBL] [Abstract][Full Text] [Related]
23. Clinical impact of breast MRI with regard to axillary reverse mapping in clinically node positive breast cancer patients following neo-adjuvant chemotherapy.
Beek MA; Tetteroo E; Luiten EJ; Gobardhan PD; Rutten HJ; Heijns JB; Voogd AC; Klompenhouwer EG
Eur J Surg Oncol; 2016 May; 42(5):672-8. PubMed ID: 26898838
[TBL] [Abstract][Full Text] [Related]
24. Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy-A Rare Event.
Barrio AV; Montagna G; Mamtani A; Sevilimedu V; Edelweiss M; Capko D; Cody HS; El-Tamer M; Gemignani ML; Heerdt A; Kirstein L; Moo TA; Pilewskie M; Plitas G; Sacchini V; Sclafani L; Tadros A; Van Zee KJ; Morrow M
JAMA Oncol; 2021 Dec; 7(12):1851-1855. PubMed ID: 34617979
[TBL] [Abstract][Full Text] [Related]
25. Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study.
Morency D; Dumitra S; Parvez E; Martel K; Basik M; Robidoux A; Poirier B; Holloway CMB; Gaboury L; Sideris L; Meterissian S; Boileau JF
Ann Surg Oncol; 2019 Dec; 26(13):4337-4345. PubMed ID: 31605348
[TBL] [Abstract][Full Text] [Related]
26. Is Breast Magnetic Resonance Imaging an Accurate Predictor of Nodal Status After Neoadjuvant Chemotherapy?
Cortina CS; Gottschalk N; Kulkarni SA; Karst I
J Surg Res; 2021 Jan; 257():412-418. PubMed ID: 32892139
[TBL] [Abstract][Full Text] [Related]
27. Luminal A Breast Cancer: How Feasible is Omitting Axillary Dissection Without Neoadjuvant Therapy.
Yüksel C; Aksel B; Doğan L
Breast J; 2022; 2022():8284814. PubMed ID: 35974878
[TBL] [Abstract][Full Text] [Related]
28. Effect of Neoadjuvant Chemotherapy on Axillary Lymph Node Positivity and Numbers in Breast Cancer Cases.
Uyan M; Koca B; Yuruker S; Ozen N
Asian Pac J Cancer Prev; 2016; 17(3):1181-5. PubMed ID: 27039745
[TBL] [Abstract][Full Text] [Related]
29. Possibility of avoiding axillary lymph node dissection by immune microenvironment monitoring in preoperative chemotherapy for breast cancer.
Takada K; Kashiwagi S; Goto W; Asano Y; Takahashi K; Fujita H; Takashima T; Tomita S; Hirakawa K; Ohira M
J Transl Med; 2018 Nov; 16(1):318. PubMed ID: 30454008
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Nomogram for Prediction of Axillary Pathologic Complete Response After Neoadjuvant Chemotherapy in Cytologically Proven Node-Positive Breast Cancer.
Kim JY; Park HS; Kim S; Ryu J; Park S; Kim SI
Medicine (Baltimore); 2015 Oct; 94(43):e1720. PubMed ID: 26512562
[TBL] [Abstract][Full Text] [Related]
31. Factors affecting lymph node yield in patients undergoing axillary node dissection for primary breast cancer: a single-institution review.
Lee MC; Plews R; Rawal B; Kiluk JV; Loftus L; Laronga C
Ann Surg Oncol; 2012 Jun; 19(6):1818-24. PubMed ID: 22203185
[TBL] [Abstract][Full Text] [Related]
32. Advantages of preoperative localization and surgical resection of metastatic axillary lymph nodes using magnetic seeds after neoadjuvant chemotherapy in breast cancer.
Mariscal Martínez A; Vives Roselló I; Salazar Gómez A; Catanese A; Pérez Molina M; Solà Suarez M; Pascual Miguel I; Blay Aulina L; Ríos Gozálvez C; Julián Ibáñez JF; Rodríguez Martínez P; Martínez Román S; Margelí Vila M; Luna Tomás MA
Surg Oncol; 2021 Mar; 36():28-33. PubMed ID: 33285433
[TBL] [Abstract][Full Text] [Related]
33. Axillary reverse mapping (ARM) in clinically node positive breast cancer patients.
Beek MA; Gobardhan PD; Klompenhouwer EG; Rutten HJ; Voogd AC; Luiten EJ
Eur J Surg Oncol; 2015 Jan; 41(1):59-63. PubMed ID: 25468747
[TBL] [Abstract][Full Text] [Related]
34. Omission of Axillary Lymph Node Dissection is Associated with Inferior Survival in Breast Cancer Patients with Residual N1 Nodal Disease Following Neoadjuvant Chemotherapy.
Almahariq MF; Levitin R; Quinn TJ; Chen PY; Dekhne N; Kiran S; Desai A; Benitez P; Jawad MS; Gustafson GS; Dilworth JT
Ann Surg Oncol; 2021 Feb; 28(2):930-940. PubMed ID: 32712895
[TBL] [Abstract][Full Text] [Related]
35. Sentinel Lymph Node Biopsy in Breast Cancer Patients With Pathological Complete Response in the Axillary Lymph Node After Neoadjuvant Chemotherapy.
Kim H; Han J; Kim SY; Lee ES; Kang HS; Lee S; Jung SY; Lee E
J Breast Cancer; 2021 Dec; 24(6):531-541. PubMed ID: 34979599
[TBL] [Abstract][Full Text] [Related]
36. A Novel Less-invasive Approach for Axillary Staging After Neoadjuvant Chemotherapy in Patients With Axillary Node-positive Breast Cancer by Combining Radioactive Iodine Seed Localization in the Axilla With the Sentinel Node Procedure (RISAS): A Dutch Prospective Multicenter Validation Study.
van Nijnatten TJA; Simons JM; Smidt ML; van der Pol CC; van Diest PJ; Jager A; van Klaveren D; Kam BLR; Lobbes MBI; de Boer M; Verhoef K; Koppert LB; Luiten EJT
Clin Breast Cancer; 2017 Aug; 17(5):399-402. PubMed ID: 28487053
[TBL] [Abstract][Full Text] [Related]
37. Are the ACOSOG Z0011 Trial Findings Being Applied to Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy?
Kantor O; Pesce C; Liederbach E; Wang CH; Winchester DJ; Yao K
Breast J; 2017 Sep; 23(5):554-562. PubMed ID: 28295828
[TBL] [Abstract][Full Text] [Related]
38. Surgical Management of the Axilla in Patients with Occult Breast Cancer (cT0 N+) After Neoadjuvant Chemotherapy.
Cohen BL; Collier AL; Kelly KN; Goel N; Kesmodel SB; Yakoub D; Moller M; Avisar E; Franceschi D; Macedo FI
Ann Surg Oncol; 2020 Jun; 27(6):1830-1841. PubMed ID: 31989360
[TBL] [Abstract][Full Text] [Related]
39. Patterns of Failure in Women Who Have Residual Nodal Disease After Neoadjuvant Chemotherapy for Breast Cancer According to Extent of Lymph Node Surgery.
Kozak MM; Horst KC; Gutkin PM; Jacobson CE; Walck E; von Eyben R; Dirbas FM
Clin Breast Cancer; 2020 Oct; 20(5):431-438. PubMed ID: 32522481
[TBL] [Abstract][Full Text] [Related]
40. Axillary management for patients with breast cancer after neoadjuvant chemotherapy: Results of a survey among Brazilian breast surgeons.
Frasson AL; Resende HM; Lichtenfels M; Barbosa F; de Souza ABA; Miranda I; Falcone AB
J Surg Oncol; 2020 Nov; 122(6):1247-1251. PubMed ID: 33045117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]